Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

46.38
+0.96002.11%
Volume:153.78K
Turnover:7.15M
Market Cap:1.60B
PE:-11.71
High:47.16
Open:45.82
Low:45.82
Close:45.42
Loading ...

Disc Medicine Inc - Commences $200 Million Underwritten Offering

THOMSON REUTERS
·
22 Jan

Disc Medicine Inc - Proceeds to Fund Research and Clinical Development

THOMSON REUTERS
·
22 Jan

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
22 Jan

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
22 Jan

Disc Medicine Price Target Maintained With a $118.00/Share by HC Wainwright & Co.

Dow Jones
·
22 Jan

H.C. Wainwright Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
22 Jan

Disc Medicine Reports 'Positive' Feedback From FDA Meeting

MT Newswires Live
·
22 Jan

Disc Medicine’s Promising Path: Buy Rating Backed by Regulatory Milestones and Market Potential

TIPRANKS
·
22 Jan

Disc Medicine Inc : Scotiabank Raises Target Price to $73 From $70

THOMSON REUTERS
·
21 Jan

Wedbush Raises Price Target on Disc Medicine to $90 From $83, Keeps Outperform Rating

MT Newswires Live
·
21 Jan

Disc Medicine announces feedback from Type C meeting with FDA

TIPRANKS
·
21 Jan

Disc Medicine Announces Successful Type C Meeting With FDA for Bitopertin in Erythropoietic Protoporphyria (Epp) and Shares Plans for Nda Submission

THOMSON REUTERS
·
21 Jan

Disc Medicine Inc - Planning to Submit Nda Under Accelerated Approval Pathway in H2 2025

THOMSON REUTERS
·
21 Jan

Disc Medicine : Plans to Initiate Apollo Trial by Mid-2025 and Will Include Sites in US, Canada, Europe, and Australia

THOMSON REUTERS
·
21 Jan

Disc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA Submission

GlobeNewswire
·
21 Jan

Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

GlobeNewswire
·
21 Jan

Disc Medicine Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
18 Jan

Press Release: Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)

Dow Jones
·
18 Jan

BUZZ-Disc Medicine falls after flagging 'material weakness'

Reuters
·
11 Jan

BRIEF-Disc Medicine Expects To Report Material Weakness in Annual Report

Reuters
·
10 Jan